Abstract of published research articles in Ayurveda
AYU Vol. 30 Issue No. 1 (Jan.-March 2009)
Id.No.30108
A study on Shvâsahara Karma of Tâmalakî
(Phyllanthus
fraternus Webster)
*
Binay Sen **
S. D. Dubey***
V. P. Singh****
K. Tripathi
Institute ofMedical
Sciences, Banaras Hindu University, Varanasi- 5 (U. P.).
Abstract:
Tamakashvâsa as described in Âyurveda is a disease of Prânavaha
Srotas (Respiratory system) involving multiple etiopathogenesis.
The clinical features are nearly similar to that of Bronchial
asthma described in Modern medicine. This study was designed to
explore the therapeutic effect and synergistic action (if any)
of a plant Tâmalakî (Phyllanthus fraternus Webster).
Tâmalakî is included in Shvâsahara and Kâsahara groups, used in
many formulations prescribed in Shvâsaroga in Âyurveda. Research
works suggest its antihistaminic property in experimental model
and effective in non bacterial upper respiratory disorders. The
present study comprises 3 groups (each 10 patients). Group Awas treated with trial drug Ghanasattva of P.
fraternus Webster, 500mg, thrice daily, orally; while Group
B was treated with modern standard drugs (a) Tab. Theo-asthalin,
thrice daily, orally and (b) Asthalin inhaler, SOS and Group C
as combination of both therapies. Total duration of treatment
was 45 days. The observations reveal that, Group A has much
better improvement in increasing Jaranashakti (t=7.57; p<0.001)
and Ruchi (t=9.86; p<0.001) in comparison to Group B and Group
C. Moreover, Group C was found more effective in reducing
majority of sign-symptoms as such Breathlessness (t=9.00;
p<0.001), Cough (t=6.47; p<0.001), Expectoration (t=9.00;
p<0.001) Wheezing (t=7.96; p<0.001), Rhonchi (t=7.96; p<0.001),
Jaranashakti (t=4.71; p<0.01) and Ruchi (t=6.68; p<0.001).
*
Ph.D. Scholar, Department of Dravyaguna, email :
senbinay@yahoo.com**
Professor, Department of Dravyaguna ***
Professor, Department of Medicinal Chemistry ****
Professor, Department of Medicine
